Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Current Assets (2016 - 2025)

Nephros has reported Current Assets over the past 16 years, most recently at $11.2 million for Q4 2025.

  • Quarterly results put Current Assets at $11.2 million for Q4 2025, up 35.25% from a year ago — trailing twelve months through Dec 2025 was $11.2 million (up 35.25% YoY), and the annual figure for FY2025 was $11.2 million, up 35.25%.
  • Current Assets for Q4 2025 was $11.2 million at Nephros, up from $10.7 million in the prior quarter.
  • Over the last five years, Current Assets for NEPH hit a ceiling of $14.8 million in Q2 2021 and a floor of $7.4 million in Q3 2024.
  • Median Current Assets over the past 5 years was $9.1 million (2022), compared with a mean of $10.1 million.
  • Biggest five-year swings in Current Assets: plummeted 39.41% in 2022 and later surged 45.54% in 2025.
  • Nephros' Current Assets stood at $13.6 million in 2021, then plummeted by 39.41% to $8.3 million in 2022, then increased by 1.74% to $8.4 million in 2023, then fell by 1.27% to $8.3 million in 2024, then skyrocketed by 35.25% to $11.2 million in 2025.
  • The last three reported values for Current Assets were $11.2 million (Q4 2025), $10.7 million (Q3 2025), and $9.6 million (Q2 2025) per Business Quant data.